搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
来自MSN
1 小时
Scientists find the reason why people with schizophrenia hear voices — and maybe how to ...
And this could change the way we think about the disorder and how we treat it. People with schizophrenia often report hearing voices that seem to come from somewhere outside themselves. These auditory ...
StudyFinds on MSN
4 天
Unique brain activity discovered when schizophrenia patients deal with misinformation
Schizophrenia, a complex mental health disorder, profoundly impacts a patient’s cognitive abilities. Now, a new study finds ...
MedPage Today
12 天
Magnetic Stimulation Reduced Auditory Hallucinations in Patients With Schizophrenia
For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...
Neuroscience News
2 天
Brain Mapping Approach Reveals Hidden Clues to Schizophrenia
A new study identifies previously hidden brain network patterns in schizophrenia by focusing on nonlinear connectivity, ...
Too Old to Operate
2 天
Immune Dysregulation and Psychopathology in Chronic Schizophrenia
The following is a summary of “Variations in inflammatory regulators in male patients with chronic schizophrenia associated ...
National Elf Service
3 天
KarXT: an innovative and promising treatment for schizophrenia
KarXT - Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new ...
Gothamist
4 天
Jordan Neely had severe schizophrenia, expert testifies at NYC subway chokehold trial
A psychiatric expert testifying in Daniel Penny’s defense said Jordan Neely had one of the most severe histories of paranoid ...
12 天
AbbVie shares tumble after schizophrenia drug disappoints
US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms ...
STAT
12 天
Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials
AbbVie’s experimental treatment for schizophrenia failed to significantly help patients in two trials, a blow to the company.
BioPharma Dive
12 天
AbbVie’s $9B bet collapses as closely watched schizophrenia drug fails studies
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...
Yahoo Finance
11 天
AbbVie’s stock plummets over 12% after schizophrenia drug flops in Phase II trials
The Phase II trials enrolled a cumulative total of 372 patients to evaluate multiple dosing levels of emraclidine (10mg or ...
12 天
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
AbbVie stock drops after Phase 2 trials of emraclidine fail to meet primary endpoint. The company continues data analysis for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈